Sugi Predict

Sugi Predict / Compounds / SCHEMBL244093

SCHEMBL244093

SCHEMBL244093

O=Cc1ccc(O)c([N+](=O)[O-])c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH5A1 P51649 1/20 1.00
▸ ABAT P80404 1/20 1.00
▸ XDH P47989 1/20 0.62
▸ VCAM1 P19320 1/20 0.62
▸ EGFR P00533 2/20 0.61
▸ ALDH1A1 P00352 4/20 0.58
▸ MAPK1 P28482 2/20 0.58
▸ TP53 P04637 1/20 0.58
▸ HPGD P15428 1/20 0.58
▸ TSHR P16473 1/20 0.58
▸ SMN1; SMN2 Q16637 1/20 0.58
▸ GPR35 Q9HC97 1/20 0.58
▸ L3MBTL1 Q9Y468 2/20 0.56
▸ ALOX15 P16050 1/20 0.56
▸ HSD17B10 Q99714 1/20 0.56
▸ KDM4E B2RXH2 3/20 0.55
▸ PTGS2 P35354 1/20 0.55
▸ RAB9A P51151 1/20 0.55
▸ TTR P02766 1/20 0.54
▸ GSK3B P49841 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodomethane SCHEMBL27504663 0.95 ALDH5A1 (0.90) ALDH5A1ABATXDHVCAM1EGFR
SCHEMBL531632 0.85 ALDH5A1 (0.73) ALDH5A1ABATXDHVCAM1EGFR
SCHEMBL29687930 0.85 ALDH5A1 (0.73) ALDH5A1ABATXDHVCAM1EGFR
SCHEMBL28114911 0.83 ALDH5A1 (0.71) ALDH5A1ABATXDHEGFRALDH1A1
SCHEMBL5661502 0.83 ALDH5A1 (0.71) ALDH5A1ABATXDHEGFRALDH1A1
SCHEMBL31484716 0.82 ALDH5A1 (0.69) ALDH5A1ABATXDHVCAM1ALDH1A1
SCHEMBL1466944 0.82 ALDH5A1 (0.69) ALDH5A1ABATXDHVCAM1ALDH1A1
Ethylene SCHEMBL9423753 0.81 ALDH5A1 (0.65) ALDH5A1ABATXDHVCAM1EGFR
SCHEMBL8701746 0.81 ALDH5A1 (0.65) ALDH5A1ABATXDHVCAM1EGFR
SCHEMBL11239202 0.80 EGFR (0.72) ALDH5A1ABATEGFRALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1583 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120078904-A Conjugates of cytotoxic drugs and prodrug forms of the conjugates 辛迪维亚公司 2025-06-03 — — CN claimed
CN-115782344-B Polyurethane composite board for building external wall insulation and preparation process thereof 鸿厦建设有限公司 2025-04-15 — — CN claimed
CN-119818698-A Micro-molecular drug conjugate based on anisoamide targeted human prostate cancer cells, preparation method and application thereof 华东师范大学 2025-04-15 — — CN claimed
EP-3773735-B1 CONJUGATE OF CYTOTOXIC DRUG AND PRODRUG FORM OF SAID CONJUGATE SYNDIVIA (FR) 2024-07-10 — — EP claimed
CN-115626990-B Synthesis and polymerization method of AB type polybenzoxazole monomer containing benzimidazole structure 浙江理工大学 2024-06-14 — — CN claimed
CN-118131564-A ArF photoresist composition with good adhesion and preparation process thereof 江西中科南新材料科技研发中心有限公司 2024-06-04 — — CN claimed
CN-118085029-A Enzyme-responsive controlled-release antibiotic prodrug, and preparation method and application thereof 国家纳米科学中心 2024-05-28 — — CN claimed
US-11918671-B2 Multi-tone hair dyeing method in three steps HENKEL AG & CO. KGAA (DE) 2024-03-05 — — US claimed
CN-117447492-A Polypyridine ligand for magnesium ion detection, iridium complex probe and preparation thereof 南京邮电大学 2024-01-26 — — CN claimed
CN-115782344-A Polyurethane composite board for building exterior wall insulation and preparation process thereof 鸿厦建设有限公司 2023-03-14 — — CN claimed
US-6635090-B1 Dyeing method using a specific cationic derivative and a compound selected among a specific aldehyde, a specific ketone, a quinone and a di-imino-isoindoline or 3-amino-isoindolone derivative L'OREAL, S.A. (FR) 2003-10-21 — — US claimed
WO-2003030845-A1 AGENT FOR THE COLORATION OF KERATIN-CONTAINING FIBERS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2003-04-17 — — WO claimed
WO-2003030842-A1 AGENT FOR COLOURING FIBRES CONTAINING KERATIN HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2003-04-17 — — WO claimed
WO-2003030847-A1 AGENT FOR COLOURING FIBRES CONTAINING KERATIN HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2003-04-17 — — WO claimed
EP-1300133-A2 Agent for dyeing keratinous fibres Henkel Kommanditgesellschaft auf Aktien (DE) 2003-04-09 — — EP claimed
EP-1300132-A2 Agent for dyeing keratinous fibres Henkel Kommanditgesellschaft auf Aktien (DE) 2003-04-09 — — EP claimed
US-6458168-B1 Hair dyeing method using an aliphatic cationic amine and compound chosen from an aldehyde, a ketone, a quinone, a di-imino-isoindoline, and a 3-aminoisoindolone derivative L'OREAL S.A. (FR) 2002-10-01 — — US claimed
US-6451067-B1 HAIR DYE MIXTURE L'OREAL S.A. (FR) 2002-09-17 — — US claimed
WO-2000038634-A1 AGENT FOR DYING KERATIN FIBERS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2000-07-06 — — WO claimed
US-5239081-A Preparation of photographic compounds EASTMAN KODAK COMPANY (US) 1993-08-24 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11918671-B2 Multi-tone hair dyeing method in three steps TYR, HAO2, HAAO ALDH5A1 52/4885ABAT 264/4885XDH 1065/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.